Upload your care plan or health regimen. Get a clinical-evidence audit.
Free preview of the gaps in your plan — no account, nothing charged up front
$1 — the full PDF audit report
$50 — your individualized evidence bundle, to upload into your own AI (ChatGPT, Claude, Gemini)
✓
We’re on it.
We’ll email your report — or reply first with a couple of quick questions to make it fit your situation — usually within a day.
Sample clinical-evidence audit
Personal context
A healthy 72-year-old — no prior heart attack, anxious about falling.
Doctor’s recommendation
“Starting daily aspirin at your age is a delicate balance — pros and cons to weigh. And a daily vitamin D supplement is a sensible step to help prevent falls.”
Flag 1 · Aspirin questionable accuracy
Second-opinion question
“The big trials at my age found more bleeding than benefit from daily aspirin — is there newer evidence, or a reason specific to me, that changes the equation?”
Clinical study evidence
USPSTF (2022) recommends against it for healthy adults 60+; ASPREE (NEJM 2018): no net benefit, more bleeding in 70+.
Flag 2 · Vitamin D questionable accuracy
Second-opinion question
“Does a daily vitamin D supplement actually lower my risk of falls, given USPSTF recommends against it for healthy older adults?”
Clinical study evidence
USPSTF recommends against it to prevent falls in healthy adults 60+; Sanders 2010 (JAMA): a high annual dose increased falls.
Flag 3 · Exercise missed evidence
Second-opinion question
“Should I be doing balance and strength training to prevent falls? My plan didn’t mention it — I’ve read it works far better than vitamin D.”
Clinical study evidence
Cochrane (2019): balance + functional exercise cuts falls ~24% (high-certainty); with strength training, ~34%; Tai Chi ~19%. Vitamin D does not.
A man in his 30s, ~265 lb (BMI 34), on a stimulant for ADHD, no diabetes. Goal: reach 200 lb.
The AI plan (OpenEvidence, refined in ChatGPT)
“Titrate oral semaglutide up to 25 mg and the weight comes off.”
Flag 1 · Muscle loss missed evidence
Second-opinion question
“How much of what I lose is muscle — and does lifting change that?”
Clinical study evidence
A 2026 meta-analysis: ~25–40% of GLP-1 weight loss is lean mass (semaglutide 35%) — roughly halved with resistance training.
Flag 2 · No exit plan missed evidence
Second-opinion question
“What happens to the weight when I stop?”
Clinical study evidence
STEP-4 (JAMA 2021): ~two-thirds of the loss returns within a year of stopping — unless muscle and the root were handled first.
Flag 3 · The root, never measured questionable accuracy
Second-opinion question
“Does the drug fix the metabolic cause, or just mask the appetite?”
Clinical study evidence
RCT (n=195): exercise raised the body’s own GLP-1 +37%; the drug left it unchanged. Appetite quieted, cause still running.
The person is a de-identified composite; the evidence is real. See the full audit → — what OpenEvidence said, how ChatGPT improved it, and what NoBSmed caught.
Personal context
An adult with PCOS, insulin resistance, and ADHD — on a medication + supplement stack.
What the audit found
It surfaces the unmeasured root cause (insulin resistance) the plan runs on, and questions a proposed metformin removal.